Published in:
Open Access
01-12-2017 | Letter
Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: comment on the article “Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis” by Bugatti et al.
Authors:
Santos Castañeda, Irene Llorente, Rosario García-Vicuña, Isidoro González-Álvaro
Published in:
Arthritis Research & Therapy
|
Issue 1/2017
Login to get access
Excerpt
We read with great interest the article about the relationship between anti-citrullinated protein antibodies (ACPA), rheumatoid factor (RF) and systemic bone loss in 155 patients with early untreated rheumatoid arthritis (RA), published recently in
Arthritis Research & Therapy [
1]. The work is really interesting since it shows the association of ACPA with low bone mass in both lumbar spine and total hip in patients with early RA [
1]. These findings are supported by recent investigations demonstrating the expression of citrullinated antigens on the surface of osteoclastic linage cells, which converts these cells into prime targets for circulating ACPA [
2,
3]. …